Nanologica AB (publ) (STO:NICA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.6040
-0.0180 (-2.89%)
Apr 24, 2026, 5:29 PM CET
Market Cap72.46M -16.7%
Revenue (ttm)21.13M +45.3%
Net Income-51.29M
EPS-0.58
Shares Out119.97M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume15,570,677
Average Volume5,435,423
Open0.6960
Previous Close0.6220
Day's Range0.5500 - 0.7420
52-Week Range0.3300 - 2.2500
Beta-0.34
RSI50.78
Earnings DateApr 24, 2026

About Nanologica AB

Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and pu... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 19
Stock Exchange Nasdaq Stockholm
Ticker Symbol NICA
Full Company Profile

Financial Performance

In 2025, Nanologica AB's revenue was 21.13 million, an increase of 45.32% compared to the previous year's 14.54 million. Losses were -51.29 million, -21.85% less than in 2024.

Financial Statements